Figure 2.
KIR 2DS1 interaction with HLA-C2 does not show any association with relapse. Cumulative incidence curve depicting relapse in the presence or absence of KIR 2DS1 and its ligand HLA-C2 does not show any difference in outcome.
KIR 2DS1 interaction with HLA-C2 does not show any association with relapse. Cumulative incidence curve depicting relapse in the presence or absence of KIR 2DS1 and its ligand HLA-C2 does not show any difference in outcome.
